Herzog Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Jerusalem Israel (1895)

Organization Overview

First Clinical Trial
2003
NCT00215878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

creatine (1 trial)

d-serine (6 trials)

Drugs in Phase 2 Trials (3)

cycloserine (seromycin) (1 trial)

olanzapine (zyprexa) (1 trial)

sarcosine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 2)

Dyskinesias (Phase 3)

Mental Disorders (Phase 2)

Parkinson Disease (Phase 4)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 3)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Tardive Dyskinesia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 5